alexa Infectious Diseases Conferences Journals | Infectious Diseases Journal
Scientific Research and information

Make the best use of Researched information from 700+ peer reviewed, Open Access Journals operated by 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business

Meet Inspiring Speakers and Experts

Infectious Diseases Conferences

Share this page  Facebook  Twitter  LinkedIn  Google+  Pinterest   Blogger

Conference Series LLC in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , RetrovirusesFlu, HIV and Epidemiology

Market Analysis
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.

Conference Series LLC 
Conference Series LLC, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.

Conference Series LLC are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.

Scope& Importance
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.

The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.

 
Rare Diseases and Orphan Drugs

With the overwhelming success of the previous conference, “2nd Annual Congress on Rare Diseases and Orphan Drugs” is going to be held during October 30-November 1, 2017 in San Antonio, USA based upon theme “Platform to share new treatments and research for Rare Diseases”. Rare diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. The organizing committee is gearing up for an exciting and informative conference program including prompt keynote presentations, Oral talks, Poster presentations and Exhibitions which provides a  platform to discuss and learn about Rare Diseases, rare cancer, malignant glioma, Turner syndrome, Multiple myeloma, Renal cell carcinoma, Hepatocellular carcinoma, Morgellons , Diabetes in the young, Systemic Amyloidosis, Autoimmune diseases, Disorders of genetic origin, idiopathic disorders, rare genetic diseases, Orphan Drugs, Alzheimer’s Disease and many more. Right now drugs for rare diseases are the sweet spot of the biotechnology industry. Treatments for illnesses that affect only hundreds of patients can cost $200,000 or more and have built Genzyme into one of biotech’s biggest companies and Alexion and Biomarin into two of its hottest names for investors.

Related Conferences:
International Congress on Infectious Diseases May 11-12, 2017, Barcelona, Spain; 5th International Congress on Bacteriology and Infectious Diseases May 25-26, 2017, Chicago, USA; 3rd World Congress on Rare Diseases June 29-30, 2017, London, UK; 3rd International Conference on Retroviruses and Novel Drugs July 27-28, 2016, Vancouver, Canada; 4th Euro-Global Conference on Infectious Diseases September 7-9, 2017, Paris, France

Flu 2017

Flu 2017 will be scheduled during Oct 30-Nov 02, 2017, Las Vegas, USA. We have done our outmost to get rid of the traditional approach in the elaboration of the program and most importantly, during the active sessions, in order to foster innovation and scientific curiosity. The theme for Flu 2017 is “Understanding the Flu; Risk Analysis and Prevention”. The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years.

Related Conferences:
2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30- Nov 1, 2017, San Antonio USA; 4th Euro-Global Conferences on Infectious Diseases, during September 07-09, 2017, Paris, France; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; 5th International Congress on Bacteriology and Infectious Diseases, May 25-26, 2017 Chicago, Illinois, USA; International Conference on Retroviruses and Novel Drugs, July 27-28, 2017 Vancouver, Canada; Sixth International Conference on Infectious Disease Dynamics 29 November-1 December, 2017 Sitges (near Barcelona), Spain; 35th Annual Infectious Diseases Conference, February 3-4, 2017 Sacramento, CA, United States; 24th Conference on Retroviruses and Opportunistic Infections, February 13-16, 2017 Seattle, USA; 27th European Congress of Clinical Microbiology and Infectious Diseases, April 22-25, 2017 Vienna, Austria.

Infection prevention and control

Infection prevention and control is required to prevent the transmission of communicable diseases in all health care settings. Infection prevention and control demands a basic understanding of the epidemiology of diseases; risk factors that increase patient susceptibility to infection; and the practices, procedures and treatments that may result in infections. The risk of acquiring a healthcare-associated infection is related to the mode of transmission of the infectious agent (e.g. CDI, SSI, CRE, MRSA, etc.) and the type of patient-care activity or procedure being performed and the underlying patient’s host defences. The conference attains significance when we look at the worldwide deaths due to Infectious Diseases. Tetanus (500,000), Measles (1 million), HIV/AIDS (1 million), Hepatitis B (1.1million), Malaria (2.1million), Diarrhoea (3.1 million), Tuberculosis (3.1 million) and Respiratory Infections (4.4 million).

Related Conferences
3rd World Congress on Infectious Diseases, Aug 21-23, 2017 USA, 2nd Annual Conference on Rare Diseases and Orphan Drugs, Oct 30-Nov 01, 2017 USA, 3rd International Conference on Influenza and Zoonotic Diseases, Aug 21-22, 2017 UK, 4th International Conference on Chronic Obstructive Pulmonary Disease (COPD), May 29-31, 2017 Japan, 3rd International Conference on Flu, Oct 30-Nov 01, 2017 USA, Keystone Symposia: New developments in our basic understanding of tuberculosis, Jan 14-18, 2017 Canada, 35th UC Davis Annual infectious diseases conference, Feb 03-04, 2017 USA, 24th Conference on retroviruses and opportunistic infections, Feb 13-16, 2017 USA, Keystone Symposia Malaria: From innovation to eradication, Feb 19-23, 2017 Uganda, Australasian society for infectious diseases annual scientific meeting, Mar 29-Apr 01, 2017 Australia.

Infection congress 2018

Infection Congress 2018 March 01-02, 2018, Berlin, Germany

Infectious Diseases Conferences Infection Conferences | Infection Congress 2018

Theme: Emergence, Insight of New Techniques in Infectious Diseases & Prevention, Control

Target Audience : Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists, Business Entrepreneurs, Health Care Associations & Societies, Health Care Professionals, Researchers Fellowship, Current antibiotic market and preventable or treatable diseases, Emerging new approaches and technologies in antibiotic resistance, Leading companies’ analysis and their strategies, Resistance trends and geographic analysis, Upcoming regulatory trends

Conference Highlights Includes:
Infection and Immune System | Host and Microbial Genetics | Food & Water Borne Infectious diseases | Microbes and Infections | Host and Pathogen Interactions | Pediatric Infectious Diseases | Infections Pathogen Biology | Hemorrhagic Fevers | Inflammatory Infectious Diseases | Vector borne Infectious diseases | Zoonotic Infectious Diseases | Neglected & Tropical Infectious diseases | Rare Infectious diseases | Infection prevention & Control | Airborne & Contact Infectious Diseases | Epidemiology - Infectious Diseases | Laboratory Diagnosis - Infectious diseases | Health Care - Infectious Diseases

Vaccines Summit 2018

Vaccines Conferences | Immunology Conferences | World Vaccine Congress

29th International Conference on Vaccines and Immunization scheduled during March 19-20, 2018 in London, UK incorporates thought provoking Keynote presentations, Oral talks, Poster presentations and Exhibitions. Vaccines Summit 2018 highlights the theme “Highlights of latest technologies and innovations in Vaccines and Immunization”. This meeting could be an outstanding occasion that brings along a novel and International blend of goliath and medium awareness on antibodies and inoculation, driving colleges inciting the gathering a perfect stage to distribute skill, cultivate coordinated efforts crosswise over exchange and world and evaluate raising advancements over the world.

Conference Highlights 
Human Vaccines against Infectious Diseases; Cancer, Malaria & TB Vaccines; HIV Vaccines; Immunizations & Bioterrorism; Combination & Conjugate Vaccines; DNA & Synthetic Vaccines; Travel & Edible Vaccines; Paediatric Vaccination; Vaccines for Immune Mediated Diseases; Veterinary Vaccines; Fish & Poultry Vaccines; Vaccines against Drugs‎; Vaccines & Autism; Vaccine Conferences 2018 USA; Geriatric Immunization; Vaccines for Pregnant Women & Neonates; Vaccines for Unconventional Diseases; Vaccine Conferences 2018 Middle east ; Animal Models & Clinical Trials; Animal & Plant Derived Vaccines; Vectors, Adjuvants & Delivery Systems; Vaccine Production & Development; Cellular Immunology & Latest Innovations; Antibodies: Engineering & Therapeutics; Current Research & Future Challenges.

Rare Diseases Congress 2018

Rare Diseases Congress 2018 June 11-12, 2018 Dublin, Ireland

Rare Diseases Conferences| Orphan Drugs Conferences| Rare Diseases Conferences 2018

Theme:Connect Together for Better Care and Innovations in Rare Disorders without Borders

Target Audience : Pathologists, Infectious Diseases Specialists, Pharmacists, Epidemiologists, Health Care Professionals, Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Researchers, Training Institutes, Pharmaceutical Companies, Rare Diseases Associations

Conference Highlights:
Neglected Tropical Diseases, Rare Pulmonary Diseases, Rare Diseases in Neurology, Rare Genetic Diseases, Scope of Orphan Drugs, Rare Cardiac Diseases, Rare Gastrointestinal Diseases, Rare diseases in Nephrology, Clinical Research on Orphan Drugs, Rare Diseases in Oncology, Rare Diseases in Haematology, Pediatric Rare Diseases, Current Rare Diseases Research, Diagnosis and Treatment for Rare Diseases, Clinical case studies on Rare Diseases, Imaging of Rare Diseases, Other Rare Diseases

Euro Vaccines 2018

Vaccines Conferences | Immunology Conferences | World Vaccine Congress Europe

30th Euro Global Summit and Expo on Vaccines & Vaccination going to be held during June 14-16, 2018 Barcelona, Spain brings people together who have an interest in different fields of vaccination and therapeutics. The conference highlights the theme “Roadmap on the future of Vaccines Research”. It is a forum to explore issues of common interest and exchange knowledge, share evidence, ideas, and generate solutions. Euro Vaccines 2018 specifically designed for physicians (family, infectious disease specialists, internists, and pediatricians), nurse practitioners, nurses, physician assistants, pharmacists, public health professionals, vaccines program administrators, and other healthcare professionals interested in clinical aspects of vaccine delivery.

Conference Highlights:

Human Vaccines - Infectious & Non Infectious Diseases, Vaccine Research & Development, HIV Vaccines, Cancer Vaccines, Childhood Vaccines, Vaccine Safety & Efficacy, Asian Vaccines Conferences 2018,Vaccination for pregnant women, Vaccine Adjuvants & Delivery Technologies, Veterinary vaccines, Geriatric Immunization,  Vaccines against Viral & Bacterial Diseases, American Vaccines Conferences 2018, Human Preventive & Therapeutic Vaccines, Hepatitis Vaccines, DNA Vaccines,  Mucosal Vaccines,  Plant-based Vaccines, HPV Vaccines, Travel Immunization, Vaccines against Vector-borne Diseases, Tuberculosis Vaccines

Influenza 2018

Influenza 2018, July 2-3, 2018 Vienna, Austria

Influenza Conferences |Influenza Meetings| Respiratory Conferences

Theme: New approaches to outbreak surveillance of Influenza and Zoonotic diseases

Target Audience : Microbiologists , Virologists Epidemiologists, Health care professionals Research scholars Vaccinologists, Immunologists, Virologists, Health-Care Professionals, Training Institutes ,Universities and Colleges Students, Associations and Societies, Pharmaceutical and Healthcare Companies, Business Entrepreneurs,  Medical colleges, Infectious Diseases Researchers, Viral Diseases Researchers

Conference Highlights:
Influenza Outbreaks, Zoonotic Diseases: Global Infectious Disease Burden, Influenza Vaccines and Vaccination, Epidemiology of Zoonotic Influenza, Influenza and other Respiratory Tract Infection Therapy, Pathogenesis of Influenza Virus, Evolution and Epidemiological Aspects of Influenza and Zoonotic Diseases,

Emerging Diseases 2018

Emerging Diseases 2018 August 27-28, 2018, Zurich, Switzerland

Infectious Conferences | Emerging Infectious Diseases Conferences | Infectious Diseases Conferences 2018

Theme: Abolish emerging infectious diseases: new strategies of the era

Target Audience: microbiologists, Bacteriologists, virologists, parasitologists, mycologist, pathologists, pharmacists, epidemiologists, health care professionals, research scholars, infectious diseases associates and societies, laboratory technicians, diagnostics companies, drug manufacturing companies, data management companies, medical colleges and, infectious Diseases Researchers.

Conference Highlights Includes:
Recent emerging infectious diseases, Sexually transmitted diseases, Pediatric infectious diseases, Microbial genomics, Modern and unique diagnostics, Veterinary infectious diseases, Advancement in vaccine and therapeuticsPublic health practice, Immunological monitoring of infections, Computational biology approach, Ebola and zika viral infections, Global trends in emerging infectious diseases, Re-emergence of neglected infectious diseases, Rare infectious disease, Public awareness.

Euro Infectious Diseases 2018

Euro Infectious Diseases 2018 September 27-29, 2018, Rome, Italy

Infectious Diseases Conferences Infection Control 2018 Euro Infection Conferences

Theme: Advancing in science and improving care to prevent the Infectious Diseases

Target Audience: Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists, Health Care Professionals and also members from Infectious Diseases Researchers, Infectious Diseases Associations and Societies, Medical Colleges, Pharmaceutical Companies and Industries, Medical Devices Manufacturing Companies, Drug Manufacturing Companies and Industries, Laboratory Technicians and Diagnostic Companies, Business Entrepreneurs and Industrialists, Training Institutes, Software Developing Companies, Data Management Companies

ConferenceHighlights:
Viral Infectious Disease, Bacterial Infectious Diseases, Fungal Infectious Diseases, Epidemiological Diseases, Dermatological Infectious Diseases, Neurological Infectious Diseases, Respiratory Infectious Diseases, Ophthalmological Infectious Diseases, Heart and Cardiovascular Infectious Diseases, Emerging Infectious Diseases, STD And HIV infections, Infection, Immunity and Inflammation, Pharmacology and Infectious Diseases, Communicable and Non communicable Infectious Diseases, Pediatric Infectious Diseases, Veterinary Infectious Diseases

STD-HIV/AIDS- 2018

STD-HIV/AIDS- 2018 October 29-30, 2018, Valencia, Spain

HIV/AIDS Conferences
| HIV/Viral Hepatitis Meetings | Sexually transmitted diseases Events

Theme: Enhance competency in HIV Prevention and Care

Target Audience: Microbiologists, Bacteriologists, Virologists, STD-AIDS associations and societies, Epidemiologists, Health care professionals, Research scholars, Medical colleges, Infectious Diseases Researchers and Viral Diseases Researchers.

Conference Highlights :
HIV/AIDS, HIV Prevention, Sexually transmitted diseases, HIV/Viral Hepatitis, Paediatric HIV Treatment Initiative, Programs in biological RetrovirologyEpidemiology of HIV infection, Immune Responses, Super and Co-Infections, Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection, Immunology of HIV/AIDS, STDs & STIs, Preventing Mother-to-Child Transmission of HIV.

 

Major Companies Related to Infectious Diseases

adwords